OBLN - Obalon Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts3133
Avg. Estimate-0.89-0.49-3.15-3.29
Low Estimate-1.5-0.49-4.89-6.04
High Estimate-0.55-0.49-1.83-1.77
Year Ago EPS-3.9-3.6-19.6-3.15
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts3133
Avg. Estimate1.21M1M3.71M9.4M
Low Estimate300k1M2.8M7.6M
High Estimate2.7M1M5.2M10.6M
Year Ago Sales2.04MN/A9.1M3.71M
Sales Growth (year/est)-40.60%N/A-59.20%153.40%
Earnings History2018-12-302019-03-302019-06-292019-09-29
EPS Est.-3.6-3.7-2.43-2.14
EPS Actual-3.9-3.6-2.5-0.61
Difference-0.30.1-0.071.53
Surprise %-8.30%2.70%-2.90%71.50%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-0.89-0.49-3.15-3.29
7 Days Ago-0.89-0.49-3.15-3.29
30 Days Ago-0.89-0.49-3.15-3.29
60 Days Ago-0.89-0.49-3.15-3.29
90 Days Ago-2.08-0.61-9.2-8.32
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesOBLNIndustrySectorS&P 500
Current Qtr.77.20%N/AN/A0.01
Next Qtr.86.40%N/AN/A0.06
Current Year83.90%N/AN/A-0.02
Next Year-4.40%N/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A